跳至主要内容
临床试验/NL-OMON45252
NL-OMON45252已完成不适用

Assessment of a novel strategy to attenuate muscle mass loss during 2 weeks of bed rest - Bed rest & Blood flow restriction

niversiteit Maastricht0 个研究点目标入组 19 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Healthy males
  • Age between 18 and 35 y
  • BMI between 18.5 and 30 kg/m2

排除标准

  • -Type 2 Diabetes Mellitus
  • -Any back/leg/knee/neck/postural complaints *
  • -Any history or family history of thrombosis*
  • -All co-morbidities interacting with mobility and muscle metabolism of the lower limbs *(e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis)
  • -Myocardial infarction within the last 3 years
  • -Use of certain anti-coagulants (use of thrombocyte aggregation inhibitors such as Ascal, *acetylsalicylic acid, aspirin and carbasalaatcalcium is permitted. Use of other thrombocyte aggregation inhibitors will be discussed with the responsible physician) *
  • -Performing regular resistance training (3+ times per week, carrying out progressive training) in the previous 6 months
  • -Hypertension (according to WHO criteria) and/or cardiovascular disease
  • -A history of deep vein thrombosis (DVT) in the leg
  • -Having donated blood in the 3 months prior to the study

研究者

相似试验

Assessment of a novel strategy to attenuate muscle... | 临床试验